These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 25595980)
21. Preclinical to clinical translation of CNS transporter occupancy of TD-9855, a novel norepinephrine and serotonin reuptake inhibitor. Smith JA; Bourdet DL; Daniels OT; Ding YS; Gallezot JD; Henry S; Kim KH; Kshirsagar S; Martin WJ; Obedencio GP; Stangeland E; Tsuruda PR; Williams W; Carson RE; Patil ST Int J Neuropsychopharmacol; 2014 Dec; 18(2):. PubMed ID: 25522383 [TBL] [Abstract][Full Text] [Related]
22. A dose-finding study of duloxetine based on serotonin transporter occupancy. Takano A; Suzuki K; Kosaka J; Ota M; Nozaki S; Ikoma Y; Tanada S; Suhara T Psychopharmacology (Berl); 2006 Apr; 185(3):395-9. PubMed ID: 16506079 [TBL] [Abstract][Full Text] [Related]
23. Relative contributions of norepinephrine and serotonin transporters to antinociceptive synergy between monoamine reuptake inhibitors and morphine in the rat formalin model. Shen F; Tsuruda PR; Smith JA; Obedencio GP; Martin WJ PLoS One; 2013; 8(9):e74891. PubMed ID: 24098676 [TBL] [Abstract][Full Text] [Related]
24. On the mechanism of antidepressant-like action of berberine chloride. Kulkarni SK; Dhir A Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703 [TBL] [Abstract][Full Text] [Related]
25. Acetaminophen Exerts an Analgesic Effect on Muscular Hyperalgesia in Repeated Cold-Stressed Rats through the Enhancement of the Descending Pain Inhibitory System Involving Spinal 5-HT Yamaguchi C; Yamamoto D; Fujimaru Y; Asano T; Takaoka A Biol Pharm Bull; 2021 Aug; 44(8):1067-1074. PubMed ID: 34135207 [TBL] [Abstract][Full Text] [Related]
26. ASP8477, a fatty acid amide hydrolase inhibitor, exerts analgesic effects in rat models of neuropathic and dysfunctional pain. Kiso T; Watabiki T; Sekizawa T Eur J Pharmacol; 2020 Aug; 881():173194. PubMed ID: 32445705 [TBL] [Abstract][Full Text] [Related]
27. Different pathophysiology underlying animal models of fibromyalgia and neuropathic pain: comparison of reserpine-induced myalgia and chronic constriction injury rats. Nagakura Y; Takahashi M; Noto T; Sekizawa T; Oe T; Yoshimi E; Tamaki K; Shimizu Y Behav Brain Res; 2012 Jan; 226(1):242-9. PubMed ID: 21945299 [TBL] [Abstract][Full Text] [Related]
28. Spontaneous pain-associated facial expression and efficacy of clinically used drugs in the reserpine-induced rat model of fibromyalgia. Nagakura Y; Miwa M; Yoshida M; Miura R; Tanei S; Tsuji M; Takeda H Eur J Pharmacol; 2019 Dec; 864():172716. PubMed ID: 31589868 [TBL] [Abstract][Full Text] [Related]
29. Duloxetine ameliorates the impairment of diffuse noxious inhibitory control in rat models of peripheral neuropathic pain and knee osteoarthritis pain. Yoneda S; Kasai E; Matsuo M; Tamano R; Sakurai Y; Asaki T; Fujita M Neurosci Lett; 2020 Jun; 729():134990. PubMed ID: 32315711 [TBL] [Abstract][Full Text] [Related]
30. Antidepressants modulate the in vitro inhibitory effects of propofol and ketamine on norepinephrine and serotonin transporter function. Zhao Y; Sun L J Clin Neurosci; 2008 Nov; 15(11):1264-9. PubMed ID: 18815045 [TBL] [Abstract][Full Text] [Related]
31. Analgesic effects of JCM-16021 on neonatal maternal separation-induced visceral pain in rats. Bian ZX; Zhang M; Han QB; Xu HX; Sung JJ World J Gastroenterol; 2010 Feb; 16(7):837-45. PubMed ID: 20143462 [TBL] [Abstract][Full Text] [Related]
32. No relationship between the ins del polymorphism of the serotonin transporter promoter and pain perception in fibromyalgia patients and healthy controls. Potvin S; Larouche A; Normand E; de Souza JB; Gaumond I; Marchand S; Grignon S Eur J Pain; 2010 Aug; 14(7):742-6. PubMed ID: 20080425 [TBL] [Abstract][Full Text] [Related]
33. Amitriptyline and duloxetine attenuate activities of superficial dorsal horn neurons in a rat reserpine-induced fibromyalgia model. Uta D; Tsuboshima K; Mizumura K; Nishijo H; Taguchi T J Pharmacol Sci; 2024 Nov; 156(3):180-187. PubMed ID: 39313276 [TBL] [Abstract][Full Text] [Related]
35. Antihypersensitivity effects of tramadol hydrochloride in a rat model of postoperative pain. Kimura M; Obata H; Saito S Anesth Analg; 2012 Aug; 115(2):443-9. PubMed ID: 22575568 [TBL] [Abstract][Full Text] [Related]
36. Restoration of 3,4-methylenedioxymethamphetamine-induced 5-HT depletion by the administration of L-5-hydroxytryptophan. Wang X; Baumann MH; Dersch CM; Rothman RB Neuroscience; 2007 Aug; 148(1):212-20. PubMed ID: 17629409 [TBL] [Abstract][Full Text] [Related]
37. The analgesia effect of duloxetine on post-operative pain via intrathecal or intraperitoneal administration. Sun YH; Li HS; Zhu C; Hu W; Yang J; Zhao GL; Lu GJ; Wu SX; Dong YL Neurosci Lett; 2014 May; 568():6-11. PubMed ID: 24686187 [TBL] [Abstract][Full Text] [Related]
38. Coexistence of Alterations of Gastrointestinal Function and Mechanical Allodynia in the Reserpine-Induced Animal Model of Fibromyalgia. Uchida M; Kobayashi O; Yoshida M; Miwa M; Miura R; Saito H; Nagakura Y Dig Dis Sci; 2019 Sep; 64(9):2538-2547. PubMed ID: 30874990 [TBL] [Abstract][Full Text] [Related]
39. Duloxetine improves chronic orofacial pain and comorbid depressive symptoms in association with reduction of serotonin transporter protein through upregulation of ubiquitinated serotonin transporter protein. Nakamura M; Yoshimi A; Tokura T; Kimura H; Kishi S; Miyauchi T; Iwamoto K; Ito M; Sato-Boku A; Mouri A; Nabeshima T; Ozaki N; Noda Y Pain; 2024 May; 165(5):1177-1186. PubMed ID: 38227563 [TBL] [Abstract][Full Text] [Related]
40. Regional differences in SERT occupancy after acute and prolonged SSRI intake investigated by brain PET. Baldinger P; Kranz GS; Haeusler D; Savli M; Spies M; Philippe C; Hahn A; Höflich A; Wadsak W; Mitterhauser M; Lanzenberger R; Kasper S Neuroimage; 2014 Mar; 88():252-62. PubMed ID: 24121201 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]